How to Join – BOTOXCosmetic.com

	Materials for Network Members
	Administering BOTOX^® Cosmetic
	Clinical Information
	Professional Organizations
	Information for Consumers

Join the BOTOX^® Cosmetic Physicians' Network

Membership in the BOTOX^® Cosmetic Physicians’ Network is available to physicians who specialize in facial aesthetic treatments (including dermatologists, maxillofacial surgeons, ophthalmologists, otolaryngologists, and plastic surgeons).

To become a member of this elite network, you are required to meet 4 preliminary criteria. You must:

Have a practice focused on facial aesthetics
Have experience in treating glabellar (frown) lines with BOTOX^® Cosmetic
Have knowledge of facial anatomy
Offer complementary or adjunctive facial aesthetic treatments

Facial aesthetic patients are customers who have high expectations of their physicians. Optimal results with BOTOX^® Cosmetic are best assured when administered by a well-trained physician with an in-depth knowledge of the muscles that control facial expression, an understanding of the dynamics of aging, and the qualifications to evaluate and determine the best aesthetic treatment option for each individual.

If you meet these criteria and would like to get started in this exciting program that will help build your practice, please call 1-800-BOTOXMD. Read more about Member Benefits.

BOTOX^® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in patients 18 to 65 years of age.

Important Safety Information

BOTOX^® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation. There have been rare reports of adverse events involving the cardiovascular system. Serious and/or immediate hypersensitivity reactions have been reported rarely. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea.

The most common adverse events following injection include blepharoptosis and nausea. Localized pain, infection, inflammation, tenderness, swelling, erythema and/or bleeding/bruising may be associated with the injection. Patients with neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious adverse events.

Please see the additional safety information and full prescribing information.

Home | Prescribing Information | Privacy Policy | Contact Allergan | Site Map